Measuring the burden of illness for end-stage renal disease: some heavy lifting required.
Estimates for the burden of illness (BOI) attributable to end-stage renal disease (ESRD) in Canada are presented in the article by Zelmer. This Commentary describes the methodology of BOI analysis, its role in formulating public policy, and the potential application to improving care for ESRD.
de Lissovoy
G
G
United BioSource Corp., Bethesda, Maryland 20814, USA. greg.delissovoy@unitedbiosource.com
D002170:Canada; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000628:therapy*; D011640:Public Policy; D011785:Quality Assurance, Health Care / Q000191:economics; D019057:Quality-Adjusted Life Years